NCT07093684 · ACTIVE NOT RECRUITING

Dementia and Kidney Disease: Epidemiological Approaches to Risk Factors and Treatment Strategies

This is an observational study, not a drug trial. Researchers are analyzing over a decade of health registry data from Sweden and other countries to map the two-way relationship between kidney disease and dementia. They want to know whether each condition worsens the other, and whether drugs used for kidneys or dementia have any protective effect on the opposite organ. No phase is listed because no intervention is being tested on participants.

You may qualify if

  • Population with dementia (all type) and kidney function measurements/Chronic kidney diagnosis

You're excluded if

  • Population lack of important baseline and follow-up information such as year of birth and sex.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-08-03

View full record on ClinicalTrials.gov

All APOE4 clinical trials